Individual results vary, and NexLife does not guarantee weight loss, treatment success, clinical outcomes, prescription approval, medication eligibility, pharmacy availability, fulfillment timelines, or delivery outcomes
We accept Visa, Mastercard, and American Express
Ozempic approved to reduce cardiovascular risk Ozempic (semaglutide 0.5 mg, 1 mg, and 2 mg) previously received FDA approval for cardiovascular health in people with type 2 diabetes after combined results from the SUSTAIN-6 and PIONEER-6 trials showed a 24% reduction in major adverse cardiac events (MACE) such as heart attack, stroke, and other cardiovascular-related deaths
Moreover, GLP-1 promotes neurogenesis by reducing inflammation and decreasing the expression of proinflammatory cytokines IL-6, IL-10, and microglial activation (25)
Get Help from Pain Specialists of Charleston Today